Regulatory authorities expand their contribution to successful drug development

In recent years, the support from regulatory authorities available to pharmaceutical companies has increased significantly, with a particular focus on SMEs.

In the latest SwedenBio’s fact sheet (in Swedish), Eva Lilienberg, Service Area Lead Global Development NDA Group, details the levels of support pharmaceutical companies can expect to receive from the authorities and how to best prepare for any agency interactions.